LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease
Open Access
- 27 February 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 2093
Abstract
Parkinson’s disease (PD) is a fatal neurodegenerative disease for which there are no still effective treatments able to stop or slow down neurodegeneration. To date, pathological mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been identified as the major genetic cause of PD, although the molecular mechanism responsible for the loss of dopaminergic neurons is still cryptic. In this review, we explore the contribution of Drosophila models to the elucidation of LRRK2 function in different cellular pathways in either neurons or glial cells. Importantly, recent studies have shown that LRRK2 is highly expressed in immunocompetent cells, including astrocytes and microglia in the brain, compared to neuronal expression. LRRK2 mutations are also strongly associated with the development of inflammatory diseases and the production of inflammatory molecules. Using Drosophila models, this paper shows that a genetic reduction of the inflammatory response protects flies from the neurodegeneration induced by LRRK2 pathological mutant expression.Keywords
Funding Information
- Bando competitivo Fondazione di Sardegna 2017-Iaccarino (FAR2020, DM 737/2021, DM 737/2021)
- Fondazione di Sardegna Annualità 2022–2023 Progetti di ricerca di base dipartimentali (FAR2020, DM 737/2021, DM 737/2021)
- Fondo di Ateneo per la Ricerca 2020 (FAR2020, DM 737/2021, DM 737/2021)
- Bando interno per la ricerca collaborativa tra Ateneo di Sassari e Ateneo di Cagliari-Formato (FAR2020, DM 737/2021, DM 737/2021)
- Bando interno per la ricerca collaborativa tra Ateneo di Sassari e Ateneo di Cagliari (FAR2020, DM 737/2021, DM 737/2021)
- Risorse 2022–2023-Formato (FAR2020, DM 737/2021, DM 737/2021)
- Progetti di ricerca interdisciplinare (FAR2020, DM 737/2021, DM 737/2021)
- Risorse 2021–2022, NextGenerationEU (FAR2020, DM 737/2021, DM 737/2021)
- PhD fellowship (Borsa di Ateneo, Università di Sassari, 2021) (FAR2020, DM 737/2021, DM 737/2021)
This publication has 97 references indexed in Scilit:
- LRRK2 Kinase Inhibitor PF-06447475 Protects Drosophila melanogaster against Paraquat-Induced Locomotor Impairment, Life Span Reduction, and Oxidative StressNeurochemical Research, 2024
- Recent advances in targeting leucine-rich repeat kinase 2 as a potential strategy for the treatment of Parkinson’s diseaseBioorganic Chemistry, 2023
- LRRK2 phosphorylation of Rab GTPases in Parkinson's diseaseFEBS Letters, 2022
- The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylationBrain Research, 2022
- Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced NeurotoxicityNeuroMolecular Medicine, 2019
- Overexpression of antimicrobial peptides contributes to aging through cytotoxic effects in Drosophila tissuesArchives of Insect Biochemistry and Physiology, 2018
- Regulation of LRRK2 by Phosphatases2017
- Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s DiseaseCell, 2014
- Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine‐rich repeat kinase 2Glia, 2014
- Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in DrosophilaBiochemical and Biophysical Research Communications, 2007